With European CE mark approval being essential to a robust global market, and with increasing demands on post market study requirements by Notified Bodies, a strong European clinical trial infrastructure is more critical than ever. For companies with either little or no presence in the geography, management of clinical projects in Europe is burdensome both financially and in terms of internal resources. Yet companies need to foster relationships between themselves and clinical sites in a way that is not always practical with large CROs.
This is why I formed EuroClinica in January 2011. With two decades of experience working in medical device clinical trial management, with a strong focus on European clinical trials, I am at the helm of our group and ensure that we act as a liaison between your company and your European customers with:
Adding a personal touch
Whether it is by acting on your behalf directly with sites or in management of your existing European CROs or other European firms, we are able to provide a local presence as a representative of your company and ensure a high quality of customer relationship management.
A commitment to quality
We stay abreast of all current regulatory obligations within the European geography in order to assure a high level of clinical deliverables.
Focusing on strategic opportunities
As your eyes and ears on the ground in Europe, we are able to develop strategic insight into your product adoption in this geography. We are able to take our strong European clinical trial experience and turn it into focused recommendations that will benefit your firm.
Keeping an eye to the bottom line
Now more than ever, costs count. Whether we manage your trials directly and provide you direct cost-savings as compared to a CRO, or we work on your behalf with European CROs or medical companies, our commitment is to your bottom line.